St.Shine Optical Co Ltd
St.Shine Optical Co.,Ltd., together with its subsidiaries, manufactures, sells, and trades contact lenses, optical lenses, and related products in Asia, Europe, America, and Taiwan. The company's product portfolio includes daily disposable, frequent replacement, color, and silicone hydrogel soft contact lens, as well as cast-molded soft contact lenses. It offers its products under the Ticon brand… Read more
St.Shine Optical Co Ltd (1565) - Net Assets
Latest net assets as of June 2025: NT$6.28 Billion TWD
Based on the latest financial reports, St.Shine Optical Co Ltd (1565) has net assets worth NT$6.28 Billion TWD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$7.99 Billion) and total liabilities (NT$1.71 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$6.28 Billion |
| % of Total Assets | 78.64% |
| Annual Growth Rate | 12.66% |
| 5-Year Change | 16.56% |
| 10-Year Change | 42.75% |
| Growth Volatility | 12.17 |
St.Shine Optical Co Ltd - Net Assets Trend (2002–2024)
This chart illustrates how St.Shine Optical Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for St.Shine Optical Co Ltd (2002–2024)
The table below shows the annual net assets of St.Shine Optical Co Ltd from 2002 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$6.56 Billion | +6.87% |
| 2023-12-31 | NT$6.14 Billion | -2.10% |
| 2022-12-31 | NT$6.27 Billion | +4.97% |
| 2021-12-31 | NT$5.97 Billion | +6.14% |
| 2020-12-31 | NT$5.63 Billion | -2.38% |
| 2019-12-31 | NT$5.76 Billion | -0.73% |
| 2018-12-31 | NT$5.81 Billion | +7.68% |
| 2017-12-31 | NT$5.39 Billion | +4.14% |
| 2016-12-31 | NT$5.18 Billion | +12.70% |
| 2015-12-31 | NT$4.59 Billion | +5.93% |
| 2014-12-31 | NT$4.34 Billion | +11.62% |
| 2013-12-31 | NT$3.89 Billion | +19.93% |
| 2012-12-31 | NT$3.24 Billion | +15.00% |
| 2011-12-31 | NT$2.82 Billion | +14.17% |
| 2010-12-31 | NT$2.47 Billion | +16.14% |
| 2009-12-31 | NT$2.12 Billion | +11.65% |
| 2008-12-31 | NT$1.90 Billion | +7.45% |
| 2007-12-31 | NT$1.77 Billion | +50.34% |
| 2006-12-31 | NT$1.18 Billion | +21.84% |
| 2005-12-31 | NT$966.82 Million | +34.63% |
| 2004-12-31 | NT$718.13 Million | +17.19% |
| 2003-12-31 | NT$612.78 Million | +28.75% |
| 2002-12-31 | NT$475.95 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to St.Shine Optical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4751.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$3.51 Billion | 53.57% |
| Other Components | NT$3.04 Billion | 46.43% |
| Total Equity | NT$6.56 Billion | 100.00% |
St.Shine Optical Co Ltd Competitors by Market Cap
The table below lists competitors of St.Shine Optical Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Yanpai Filtration Technology Co.Ltd.
SHE:301081
|
$147.19 Million |
|
BerGenBio ASA
PINK:BRRGF
|
$147.25 Million |
|
Harbin Sayyas Windows Co. Ltd. A
SHE:301227
|
$147.26 Million |
|
Imperial Metals Corporation
PINK:IPMLF
|
$147.29 Million |
|
Cardinal Ethanol LLC
OTCGREY:CRDE
|
$147.10 Million |
|
APAC Opto Electronics
TWO:4908
|
$147.09 Million |
|
Dogu Aras Enerji Yatirimlari AS
IS:ARASE
|
$147.06 Million |
|
AVY Precision Technology
TWO:5392
|
$146.98 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in St.Shine Optical Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 6,136,070,000 to 6,557,910,000, a change of 421,840,000 (6.9%).
- Net income of 747,302,000 contributed positively to equity growth.
- Dividend payments of 352,916,000 reduced retained earnings.
- Other comprehensive income decreased equity by 1,959,050,000.
- Other factors increased equity by 1,986,504,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$747.30 Million | +11.4% |
| Dividends Paid | NT$352.92 Million | -5.38% |
| Other Comprehensive Income | NT$-1.96 Billion | -29.87% |
| Other Changes | NT$1.99 Billion | +30.29% |
| Total Change | NT$- | 6.87% |
Book Value vs Market Value Analysis
This analysis compares St.Shine Optical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.83x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.01x to 0.83x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | NT$106.94 | NT$107.50 | x |
| 2018-12-31 | NT$115.16 | NT$107.50 | x |
| 2019-12-31 | NT$113.57 | NT$107.50 | x |
| 2020-12-31 | NT$110.80 | NT$107.50 | x |
| 2021-12-31 | NT$117.62 | NT$107.50 | x |
| 2022-12-31 | NT$123.31 | NT$107.50 | x |
| 2023-12-31 | NT$120.68 | NT$107.50 | x |
| 2024-12-31 | NT$130.07 | NT$107.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently St.Shine Optical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.40%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 16.42%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 1.24x
- Recent ROE (11.40%) is below the historical average (25.96%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 12.30% | 16.36% | 0.56x | 1.35x | NT$10.96 Million |
| 2003 | 17.93% | 19.55% | 0.69x | 1.32x | NT$48.58 Million |
| 2004 | 23.07% | 20.40% | 0.80x | 1.41x | NT$93.84 Million |
| 2005 | 24.11% | 21.37% | 0.80x | 1.40x | NT$136.42 Million |
| 2006 | 30.70% | 22.02% | 0.85x | 1.64x | NT$243.83 Million |
| 2007 | 30.05% | 28.93% | 0.72x | 1.45x | NT$355.02 Million |
| 2008 | 29.52% | 25.85% | 0.79x | 1.44x | NT$371.47 Million |
| 2009 | 29.38% | 26.09% | 0.79x | 1.43x | NT$411.71 Million |
| 2010 | 35.35% | 28.14% | 0.86x | 1.46x | NT$625.55 Million |
| 2011 | 37.87% | 30.84% | 0.88x | 1.39x | NT$785.08 Million |
| 2012 | 37.16% | 28.88% | 0.79x | 1.62x | NT$880.00 Million |
| 2013 | 41.14% | 30.60% | 0.84x | 1.59x | NT$1.21 Billion |
| 2014 | 36.27% | 29.07% | 0.84x | 1.48x | NT$1.14 Billion |
| 2015 | 31.69% | 24.85% | 0.89x | 1.43x | NT$996.60 Million |
| 2016 | 34.34% | 27.52% | 0.88x | 1.42x | NT$1.26 Billion |
| 2017 | 29.48% | 24.76% | 0.75x | 1.60x | NT$1.05 Billion |
| 2018 | 28.72% | 24.98% | 0.76x | 1.51x | NT$1.09 Billion |
| 2019 | 22.33% | 20.28% | 0.75x | 1.46x | NT$710.89 Million |
| 2020 | 13.24% | 14.88% | 0.62x | 1.43x | NT$182.51 Million |
| 2021 | 15.87% | 17.55% | 0.63x | 1.44x | NT$350.64 Million |
| 2022 | 16.26% | 20.37% | 0.60x | 1.32x | NT$392.28 Million |
| 2023 | 8.90% | 12.43% | 0.57x | 1.26x | NT$-67.65 Million |
| 2024 | 11.40% | 16.42% | 0.56x | 1.24x | NT$91.51 Million |
Industry Comparison
This section compares St.Shine Optical Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,396,642,667
- Average return on equity (ROE) among peers: 8.88%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| St.Shine Optical Co Ltd (1565) | NT$6.28 Billion | 12.30% | 0.27x | $147.19 Million |
| Nang Kuang Pharmaceutical Co Ltd (1752) | $2.19 Billion | 9.94% | 0.50x | $46.91 Million |
| Maxigen Biotech Inc (1783) | $1.14 Billion | 7.68% | 0.11x | $53.63 Million |
| SciVision Biotech Inc (1786) | $1.02 Billion | -2.16% | 0.07x | $107.95 Million |
| Bioteque (4107) | $1.88 Billion | 15.46% | 0.25x | $198.92 Million |
| Chi Sheng Chemical (4111) | $1.22 Billion | 12.60% | 0.47x | $41.85 Million |
| Sunder Biomedical Tech. Co., Ltd. (4115) | $790.45 Million | 1.68% | 0.80x | $2.11K |
| BenQ Medical Technology (4116) | $1.10 Billion | 2.62% | 0.78x | $25.45 Million |
| Pacific Hospital Supply Co Ltd (4126) | $2.26 Billion | 10.49% | 0.61x | $128.74 Million |
| Unicon Optical Co., Ltd. (4150) | $963.23 Million | 21.57% | 0.59x | $22.68 Million |